JP2005505286A5 - - Google Patents

Download PDF

Info

Publication number
JP2005505286A5
JP2005505286A5 JP2003534559A JP2003534559A JP2005505286A5 JP 2005505286 A5 JP2005505286 A5 JP 2005505286A5 JP 2003534559 A JP2003534559 A JP 2003534559A JP 2003534559 A JP2003534559 A JP 2003534559A JP 2005505286 A5 JP2005505286 A5 JP 2005505286A5
Authority
JP
Japan
Prior art keywords
region
base pairs
nucleic acid
seq
linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003534559A
Other languages
English (en)
Japanese (ja)
Other versions
JP4475561B2 (ja
JP2005505286A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/032512 external-priority patent/WO2003031588A2/en
Publication of JP2005505286A publication Critical patent/JP2005505286A/ja
Publication of JP2005505286A5 publication Critical patent/JP2005505286A5/ja
Application granted granted Critical
Publication of JP4475561B2 publication Critical patent/JP4475561B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003534559A 2001-10-11 2002-10-10 C型肝炎ウイルスワクチン Expired - Lifetime JP4475561B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32865501P 2001-10-11 2001-10-11
US36377402P 2002-03-13 2002-03-13
PCT/US2002/032512 WO2003031588A2 (en) 2001-10-11 2002-10-10 Hepatitis c virus vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009080838A Division JP4479973B2 (ja) 2001-10-11 2009-03-30 C型肝炎ウイルスワクチン

Publications (3)

Publication Number Publication Date
JP2005505286A JP2005505286A (ja) 2005-02-24
JP2005505286A5 true JP2005505286A5 (enExample) 2006-01-05
JP4475561B2 JP4475561B2 (ja) 2010-06-09

Family

ID=42828995

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003534559A Expired - Lifetime JP4475561B2 (ja) 2001-10-11 2002-10-10 C型肝炎ウイルスワクチン

Country Status (9)

Country Link
US (3) US7598362B2 (enExample)
EP (1) EP1436397B1 (enExample)
JP (1) JP4475561B2 (enExample)
CN (1) CN1582337B (enExample)
AT (1) ATE467680T1 (enExample)
AU (1) AU2002337840B2 (enExample)
CA (1) CA2461380C (enExample)
DK (1) DK1436397T3 (enExample)
WO (1) WO2003031588A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2411096T3 (es) 1999-10-27 2013-07-04 Novartis Vaccines And Diagnostics, Inc. Activación de linfocitos T específicos contra el VHC
RU2286172C2 (ru) 2000-08-17 2006-10-27 Трипеп Аб Вакцины, содержащие рибавирин, и способы их использования
US6960569B2 (en) 2000-08-17 2005-11-01 Tripep Ab Hepatitis C virus non-structural NS3/4A fusion gene
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) * 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
AU2002337840B2 (en) * 2001-10-11 2007-08-09 Msd Italia S.R.L. Hepatitis C virus vaccine
PT1436397E (pt) * 2001-10-11 2010-07-15 Angeletti P Ist Richerche Bio Vacina de v�rus da hepatite c
JP2008518591A (ja) * 2004-11-02 2008-06-05 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー 複製欠損アデノウイルスベクターの製造のためのアデノウイルスアンプリコンおよびプロデューサー細胞、その製造方法および用途
EP1846439A2 (en) * 2005-01-31 2007-10-24 The Johns Hopkins University Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
US7951531B2 (en) * 2005-02-17 2011-05-31 University Of Iowa Research Foundation Flavivirus NS5A proteins for the treatment of HIV
DE102005015005A1 (de) * 2005-04-01 2006-10-05 Qiagen Gmbh Verfahren zur Behandlung einer Biomoleküle enthaltenden Probe
WO2007031867A2 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-stru tural ns3/4a fusion gene
EP1893636A2 (en) * 2005-06-17 2008-03-05 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Hepatitis c virus nucleic acid vaccine
CN1887350B (zh) * 2005-06-28 2010-10-06 深圳市源兴生物医药科技有限公司 一种重组疫苗及其用途
KR101357685B1 (ko) * 2005-11-21 2014-02-06 사노피 파스퇴르 리미티드 / 사노피 파스퇴르 리미떼 재조합 바이러스용 안정화 제형
EP2076531B1 (en) 2006-10-12 2011-11-23 Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof
US8124108B2 (en) 2007-01-24 2012-02-28 Merck Sharp & Dohme Corp. Polypeptides for inducing a protective immune response against Staphylococcus epidermidis
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
WO2009079834A1 (en) * 2007-12-18 2009-07-02 Peking University People's Hospital An anti-hcv vaccine and preparation methods and uses thereof
US20110136896A1 (en) * 2008-08-01 2011-06-09 Tong-Ming Fu Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof
US8921536B2 (en) 2008-10-29 2014-12-30 The Trustees Of The University Of Pennsylvania HCV vaccines and methods for using the same
AU2008363596B2 (en) 2008-10-29 2015-04-30 Inovio Pharmaceuticals, Inc Improved HCV vaccines and methods for using the same
JP2012509665A (ja) 2008-11-26 2012-04-26 メルク・シャープ・エンド・ドーム・コーポレイション スタフィロコッカス・アウレウス(staphylococcusaureus)に対する防御免疫応答を誘導するポリペプチド
CN102292105A (zh) 2008-11-26 2011-12-21 默沙东公司 用于诱导抗金黄色葡萄球菌的保护性免疫应答的多肽
MX2011007980A (es) 2009-02-02 2011-08-17 Okairos Ag Secuencias de acido nucleico y aminoacido de adenovirus de simio, vectores que contienen los mismos y usos de las mismas.
CN102645534B (zh) * 2012-04-26 2015-08-12 杭州市萧山区第一人民医院 基于量子点编码微球芯片检测丙型肝炎病毒的方法
WO2014139587A1 (en) 2013-03-15 2014-09-18 Okairòs Ag Improved poxviral vaccines
WO2017025782A1 (en) 2014-09-17 2017-02-16 Glaxosmithkline Biologicals Sa Improved poxviral vaccines
WO2016112459A1 (en) * 2015-01-15 2016-07-21 Babita Agrawal Methods of inducing an immune response to hepatitis c virus
CN108277230A (zh) * 2018-02-07 2018-07-13 华中科技大学 一种融合dna及其制备的疫苗

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173552B1 (en) 1984-08-24 1991-10-09 The Upjohn Company Recombinant dna compounds and the expression of polypeptides such as tpa
US5585362A (en) * 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
US5747339A (en) 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
EP0464287A1 (en) * 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
IT1270939B (it) 1993-05-11 1997-05-26 Angeletti P Ist Richerche Bio Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
US6140087A (en) * 1993-06-24 2000-10-31 Advec, Inc. Adenovirus vectors for gene therapy
IT1272179B (it) 1994-02-23 1997-06-16 Angeletti P Ist Richerche Bio Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.
CA2117668C (en) * 1994-03-09 2005-08-09 Izumu Saito Recombinant adenovirus and process for producing the same
US5505947A (en) 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
US6127525A (en) * 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
US5792462A (en) 1995-05-23 1998-08-11 University Of North Carolina At Chapel Hill Alphavirus RNA replicon systems
IT1278077B1 (it) 1995-05-25 1997-11-17 Angeletti P Ist Richerche Bio Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal
US5994128A (en) 1995-06-15 1999-11-30 Introgene B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
EP1009763A4 (en) * 1996-06-11 2002-08-07 Merck & Co Inc SYNTHETIC HEPATITIS-C GENES
US7049428B1 (en) * 1998-03-04 2006-05-23 Washington University HCV variants
DK1023107T3 (da) 1997-04-03 2006-12-27 Electrofect As Fremgangsmåde til indgivelse af farmaceutiske præparater og nucleinsyrer i skeletmuskulaturen
WO1998051788A2 (en) 1997-05-12 1998-11-19 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method and construct for inhibition of cell migration
US6221646B1 (en) * 1997-07-31 2001-04-24 Chiron Corporation Materials and methods for simplified AAV production
KR100628411B1 (ko) 1998-01-30 2006-09-28 더 제너럴 하스피탈 코포레이션 C형 간염 바이러스의 비구조 단백질을 이용한 유전자면역법
CA2328180A1 (en) 1998-04-14 1999-10-21 Merck & Co., Inc. Needleless administration of polynucleotide formulations
WO1999057296A1 (en) 1998-05-01 1999-11-11 Genzyme Corporation Partially deleted adenoviral vectors
GB9810756D0 (en) 1998-05-19 1998-07-15 Angeletti P Ist Richerche Bio Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
US6156588A (en) 1998-06-23 2000-12-05 Vlsi Technology, Inc. Method of forming anti-fuse structure
JP2002523054A (ja) 1998-08-24 2002-07-30 ジェンザイム・コーポレイション ポリマーにより修飾されたアデノウイルスのカチオン性複合体
IL144060A0 (en) 1999-01-14 2002-04-21 Novartis Ag Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
EP1200622A4 (en) * 1999-07-06 2004-12-22 Merck & Co Inc HIV VACCINE FROM AN ADENOVIRUS CARRYING THE GAG GENE
US6627190B2 (en) * 1999-07-12 2003-09-30 Saint Louis University Recombinant adenovirus vectors that are replication-competent in tert-expressing cells
US6511832B1 (en) * 1999-10-06 2003-01-28 Texas A&M University System In vitro synthesis of capped and polyadenylated mRNAs using baculovirus RNA polymerase
ES2411096T3 (es) * 1999-10-27 2013-07-04 Novartis Vaccines And Diagnostics, Inc. Activación de linfocitos T específicos contra el VHC
CN101684146A (zh) 1999-11-24 2010-03-31 诺华疫苗和诊断公司 新颖的hcv非结构多肽
ATE413190T1 (de) 1999-12-01 2008-11-15 Novartis Vaccines & Diagnostic Hervorrufen von antikörpern spezifisch für hepatitis c virus (hcv)
US6544780B1 (en) * 2000-06-02 2003-04-08 Genphar, Inc. Adenovirus vector with multiple expression cassettes
AU9456201A (en) 2000-09-15 2002-03-26 Merck & Co Inc Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
AU2002337840B2 (en) * 2001-10-11 2007-08-09 Msd Italia S.R.L. Hepatitis C virus vaccine

Similar Documents

Publication Publication Date Title
JP2005505286A5 (enExample)
CA2461380A1 (en) Hepatitis c virus vaccine
CA2278616C (en) Adenoviruses having altered hexon proteins
Gorziglia et al. Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy
Fisher et al. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis
EP1056881B1 (en) A simplified system for generating recombinant adenoviruses
JP4334174B2 (ja) 腫瘍崩壊性アデノウイルス
US6669942B2 (en) Defective adenoviruses including a therapeutic gene and an immunoprotectove gene
JP2004508064A5 (enExample)
JP2004501650A5 (enExample)
EP0821739B1 (en) An adenovirus helper-virus system
JP2003530307A5 (enExample)
JP2012139220A (ja) 複製欠損アデノウイルスtnfベクター
EP0968281A2 (en) An oncolytic/immunogenic complementary-adenoviral vector system
JP2001505047A (ja) 高キャパシティーアデノウイルスベクターの開発の促進に使用するためのパッケージング細胞系
CA2378586A1 (en) Replication-competent anti-cancer vectors
ES2268695T3 (es) Adenovirus recombinantes defectivos con una gen iva2 inactivado.
AU772963B2 (en) Adenoviral vectors for treating disease
WO2001002540A2 (en) Adenoviral vectors for treating disease
CN107073078A (zh) 利用肝细胞生长因子和基质细胞衍生因子1α的用于预防或治疗外周动脉疾病的组合物
JP2009535031A5 (enExample)
US7368553B2 (en) Alternatively spliced nucleic acid molecules
Hokanson et al. Hybrid yeast–bacteria cloning system used to capture and modify adenoviral and nonviral genomes
CN113774031B (zh) 一种复制型人腺病毒及其应用
AU2005209653B2 (en) Adenoviral vectors for treating disease